… ProQR Announces Financial Results for the Second Quarter of … progress towards accomplishing the goals set out in ProQR’s Vision 2023 strategy, which includes starting the … property costs and other allocated costs. The increase in R&D expenses was primarily due to initiation of the clinical …
… ProQR Announces Virtual Presentations at American Academy of … Academy of Ophthalmology (AAO) held November 13-15, 2020. ProQR’s presentations Presentation title: Phase 1b/2 trial … Leber congenital amaurosis 10 (LCA10) Presenter: Stephen R. Russell, MD, Professor and Director of Vitreoretinal …
… ProQR to Present at the RBC Capital Markets Healthcare … be accessible from the ‘Investor Relations’ section of ProQR’s website ( www.proqr.com ) under ‘Events and Presentations’. The …
… ProQR to Present at the JMP Securities Life Sciences … be accessible from the ‘Investor Relations’ section of ProQR’s website ( www.proqr.com ) under ‘Events and Presentations’. The …
… ProQR Announces Expert Perspectives Call on LCA10 and … & CAMBRIDGE, Mass., July 13, 2020 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to … presentation by Aniz Girach, MD, Chief Medical Officer of ProQR Therapeutics. Dr. Girach will then discuss the …
… ProQR Prices $75 Million Underwritten Public Offering and … (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (“ProQR”), a company dedicated to changing lives through … and commissions and other offering expenses payable by ProQR. All of the shares are being offered by ProQR. In …
… ProQR Strengthens Leading Intellectual Property Estate for … (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through … and Trademark Office (USPTO) granted a new patent to ProQR, under US patent No. 11,781,134 that relates to a …
… ProQR Announces Annual General Meeting of Shareholders and … & CAMBRIDGE, Mass., June 01, 2022 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a …